Tag:
Charité–Universitätsmedizin Berlin
News
CAR T Cells for Severe Rheumatoid Arthritis: What the First Charité Trial Shows
A first clinical trial at Charité–Universitätsmedizin Berlin suggests that CD19 CAR T-cell therapy may reduce disease activity in people with severe rheumatoid arthritis that...